{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:54:26Z","timestamp":1789163666161,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Experimental Arthritis Treatment Centre for Children","award":["ARUK-20621"],"award-info":[{"award-number":["ARUK-20621"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204822z16z"],"award-info":[{"award-number":["204822z16z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Children\/Versus Arthritis Paediatric Rheumatology Clinical Studies Group","award":["JXR30524"],"award-info":[{"award-number":["JXR30524"]}]},{"name":"National Institue for Health and Care Research"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1136\/ard-2022-223328","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T13:21:01Z","timestamp":1673356861000},"page":"788-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-7597","authenticated-orcid":false,"given":"Eve Mary Dorothy","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-5186","authenticated-orcid":false,"given":"Amita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1999-6341","authenticated-orcid":false,"given":"Eslam","family":"Al-Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Avcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Bortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-4113","authenticated-orcid":false,"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-3338","authenticated-orcid":false,"given":"Eric F","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9658-0385","authenticated-orcid":false,"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Saad Magalhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa A","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieneke","family":"Schonenberg-Meinema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-9911","authenticated-orcid":false,"given":"Michael William","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Goilav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2022-223328_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.23204","article-title":"Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus","volume":"58","author":"Brunner","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.24091","article-title":"Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus","volume":"61","author":"Hersh","year":"2009","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","article-title":"Pediatric lupus\u2013are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?","volume":"36","author":"Mina","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard-2022-223328_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0961203307087875","article-title":"Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)","volume":"17","author":"Tucker","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib5","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/0961203316644333","article-title":"Differences in disease phenotype and severity in SLE across age groups","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3899\/jrheum.081164","article-title":"Health-Related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus","volume":"36","author":"Brunner","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib8","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1093\/rheumatology\/keac064","article-title":"Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland","volume":"61","author":"Lythgoe","year":"2022","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","article-title":"Long\u2010Term clinical outcomes in a cohort of adults with Childhood\u2010Onset systemic lupus erythematosus","volume":"71","author":"Groot","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","article-title":"Prevalence and burden of pediatric-onset systemic lupus erythematosus","volume":"6","author":"Kamphuis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3899\/jrheum.191004","article-title":"Effects of childhood-onset systemic lupus erythematosus on academic achievements and employment in adult life","volume":"48","author":"Groot","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4070\/kcj.2019.0261","article-title":"Ideal target blood pressure in hypertension","volume":"49","author":"Park","year":"2019","journal-title":"Korean Circ J"},{"key":"10.1136\/ard-2022-223328_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(94)91405-2","article-title":"Pharmacological treatment of hypertension","volume":"344","author":"SWALES","year":"1994","journal-title":"The Lancet"},{"key":"10.1136\/ard-2022-223328_bib14","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0140-6736(97)90026-X","article-title":"The impact of cardiovascular disease on people with diabetes: the potential for prevention","volume":"350","author":"Eastman","year":"1997","journal-title":"The Lancet"},{"key":"10.1136\/ard-2022-223328_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/2230-8210.129106","article-title":"Treat-to-target trials in diabetes","volume":"18","author":"Wangnoo","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1136\/ard-2022-223328_bib16","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1093\/rheumatology\/keab173","article-title":"\u2018It is good to have a target in mind\u2019: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus","volume":"60","author":"Smith","year":"2021","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib17","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/rheumatology\/keab915","article-title":"Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib18","doi-asserted-by":"crossref","first-page":"e000571","DOI":"10.1136\/lupus-2021-000571","article-title":"LLDAS is an attainable treat-to-target goal in childhood-onset SLE","volume":"8","author":"Wahadat","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1136\/ard-2022-223328_bib19","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a lupus low disease activity state (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib20","doi-asserted-by":"crossref","first-page":"e000538","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international Task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1136\/ard-2022-223328_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international Task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-017-1256-6","article-title":"Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study","volume":"19","author":"Golder","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2022-223328_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13075-022-02756-3","article-title":"\u2018Not at target\u2019: prevalence and consequences of inadequate disease control in systemic lupus erythematosus\u2014a multinational observational cohort study","volume":"24","author":"Kandane-Rathnayake","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2022-223328_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international Task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/annrheumdis-2018-213902","article-title":"Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial","volume":"78","author":"Hissink Muller","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/annrheumdis-2019-216843","article-title":"Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis","volume":"79","author":"Klein","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib27","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/art.40865","article-title":"Treatment to target using recombinant Interleukin\u20101 receptor antagonist as First\u2010Line monotherapy in New\u2010Onset systemic juvenile idiopathic arthritis: results from a Five\u2010Year Follow\u2010Up study","volume":"71","author":"ter Haar","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s41927-022-00300-z","article-title":"Improving communication of the concept of \u2018treat-to target\u2019 in childhood lupus: a public and patient (PPI) engagement project involving children and young people","volume":"6","author":"Elliott","year":"2022","journal-title":"BMC Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib29","doi-asserted-by":"crossref","first-page":"109028","DOI":"10.1016\/j.clim.2022.109028","article-title":"Real world treatment of juvenile-onset systemic lupus erythematosus: data from the UK JSLE cohort study","volume":"239","author":"Smith","year":"2022","journal-title":"Clinical Immunology"},{"key":"10.1136\/ard-2022-223328_bib30","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1093\/rheumatology\/keab173","article-title":"'It is good to have a target in mind\u2019: qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus","volume":"60","author":"Smith","year":"2021","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib31","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","article-title":"European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the share initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the share initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib33","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the share initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib34","doi-asserted-by":"crossref","first-page":"884634","DOI":"10.3389\/fped.2022.884634","article-title":"What have we learnt about the treatment of juvenile-onset systemic lupus Erythematous since development of the share recommendations 2012?","volume":"10","author":"Gallagher","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1136\/ard-2022-223328_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.2042-7174.1996.tb00844.x","article-title":"The Delphi and nominal group techniques in health services research","volume":"4","author":"Cantrill","year":"2011","journal-title":"International Journal of Pharmacy Practice"},{"key":"10.1136\/ard-2022-223328_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib37","doi-asserted-by":"crossref","first-page":"819-828","DOI":"10.1136\/annrheumdis-2018-213030","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international Task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13012-018-0851-5","article-title":"Barriers and facilitators of pediatric shared decision-making: a systematic review","volume":"14","author":"Boland","year":"2019","journal-title":"Implement Sci"},{"key":"10.1136\/ard-2022-223328_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semarthrit.2019.05.010","article-title":"Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus","volume":"49","author":"Heshin-Bekenstein","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.berh.2005.11.002","article-title":"Management of adherence and chronic rheumatic disease in children and adolescents","volume":"20","author":"Rapoff","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international Task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1756-185X.12551","article-title":"Optimizing the use of existing therapies in lupus","volume":"18","author":"Croyle","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib43","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00296-014-3209-6","article-title":"Dissecting the damage in northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study","volume":"35","author":"Koutsonikoli","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard-2022-223328_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.10072","article-title":"Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage","volume":"46","author":"Brunner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib45","first-page":"1398","article-title":"High predictive value of the systemic lupus international collaborating Clinics\/American College of rheumatology damage index for survival in systemic lupus erythematosus","volume":"29","author":"Nived","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.semarthrit.2018.09.005","article-title":"Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: cluster analyses in a large cohort from the Spanish Society of rheumatology lupus registry (RELESSER)","volume":"48","author":"Torrente-Segarra","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/09612033211010330","article-title":"Systemic lupus erythematosus in children and adults: a retrospective study in Brazilian patients","volume":"30","author":"Bortolini","year":"2021","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups","volume":"29","author":"Massias","year":"2020","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42358-020-0114-4","article-title":"Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis","volume":"60","author":"Miguel","year":"2020","journal-title":"Adv Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib50","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1177\/0961203317702253","article-title":"Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE cohort study","volume":"26","author":"Smith","year":"2017","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0961203306lu2316oa","article-title":"Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus","volume":"15","author":"Bandeira","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib52","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/art.22048","article-title":"A proposal for a pediatric version of the systemic lupus international collaborating Clinics\/American College of rheumatology damage index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus","volume":"54","author":"Guti\u00e9rrez-Su\u00e1rez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib53","first-page":"261","article-title":"Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus","volume":"23","author":"Lilleby","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib54","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/acr.23199","article-title":"From childhood to adulthood: the trajectory of damage in patients with juvenile-onset systemic lupus erythematosus","volume":"69","author":"Lim","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.11205","article-title":"Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study","volume":"49","author":"Ravelli","year":"2003","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/ard-2022-223328_bib56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/art.20412","article-title":"Health-Related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage","volume":"51","author":"Ruperto","year":"2004","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12969-018-0271-8","article-title":"Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study","volume":"16","author":"Sit","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/ard-2022-223328_bib58","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","article-title":"Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort","volume":"64","author":"Watson","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/ard-2022-223328_bib59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10067-016-3518-0","article-title":"Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients","volume":"36","author":"Harris","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib60","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.22375","article-title":"Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. results from a multiethnic US cohort","volume":"56","author":"Andrade","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib61","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic lupus international collaborating clinics (SLICC) inception cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/rheumatology\/kep062","article-title":"Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years","volume":"48","author":"Chambers","year":"2009","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/acr.22650","article-title":"Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus","volume":"68","author":"Jones","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib64","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0961203319853621","article-title":"Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: a systematic review","volume":"28","author":"Quilter","year":"2019","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1546-0096-12-42","article-title":"Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study","volume":"12","author":"Knight","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/ard-2022-223328_bib66","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/0961203309355810","article-title":"Impact of lupus on school attendance and performance","volume":"19","author":"Moorthy","year":"2010","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12955-020-01351-x","article-title":"Influence of schooling on the health-related quality of life of children with rare diseases","volume":"18","author":"Paz-Lourido","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1136\/ard-2022-223328_bib68","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/acr.23531","article-title":"Measuring disease damage and its severity in Childhood\u2010Onset systemic lupus erythematosus","volume":"70","author":"Holland","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib69","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1177\/0961203318776085","article-title":"Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience","volume":"27","author":"Mahmoud","year":"2018","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0961203315619031","article-title":"Outcome of lupus nephritis in childhood onset SLE in North and central India: single-centre experience over 25 years","volume":"25","author":"Srivastava","year":"2016","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib71","first-page":"554","article-title":"Trends and predictors of mortality in childhood onset lupus in a single North-Indian centre over 23 years: a retrospective study","volume":"34","author":"Abujam","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0961203315570166","article-title":"Childhood lupus nephritis in a developing country\u201424 years' single-center experience from North India","volume":"24","author":"Singh","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10067-016-3509-1","article-title":"Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality","volume":"36","author":"Fatemi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib74","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/art.34472","article-title":"Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population","volume":"64","author":"Hiraki","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/ard-2022-223328_bib75","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpeds.2007.09.019","article-title":"Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study","volume":"152","author":"Hiraki","year":"2008","journal-title":"J Pediatr"},{"key":"10.1136\/ard-2022-223328_bib76","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","article-title":"Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome","volume":"34","author":"Tucker","year":"1995","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib77","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure","volume":"33","author":"Faurschou","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib78","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-Term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1523-1755.2000.00832.x","article-title":"Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide","volume":"57","author":"Ioannidis","year":"2000","journal-title":"Kidney Int"},{"key":"10.1136\/ard-2022-223328_bib80","doi-asserted-by":"crossref","first-page":"e001263","DOI":"10.1136\/rmdopen-2020-001263","article-title":"Management of lupus nephritis: a systematic literature review Informing the 2019 update of the joint EULAR and European renal Association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations","volume":"6","author":"Kostopoulou","year":"2020","journal-title":"RMD Open"},{"key":"10.1136\/ard-2022-223328_bib81","first-page":"S75","article-title":"What happens after complete withdrawal of therapy in patients with lupus nephritis","volume":"31","author":"Moroni","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib82","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3899\/jrheum.170226","article-title":"Longterm data on disease flares in patients with proliferative lupus nephritis in recent years","volume":"44","author":"Yap","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib83","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2014-206897","article-title":"Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis","volume":"75","author":"Tamirou","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib84","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/rheumatology\/kev003","article-title":"Assessment of long-term remission in lupus nephritis patients: a retrospective analysis over 30 years","volume":"54","author":"Fernandes das Neves","year":"2015","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib85","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2011.08.002","article-title":"Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients","volume":"41","author":"Moroni","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib86","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/annrheumdis-2011-200384","article-title":"Long-Term follow-up of a randomised controlled trial of azathioprine\/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis","volume":"71","author":"Arends","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib87","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (Aurora 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-223328_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/annrheumdis-2019-216303","article-title":"Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib89","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3899\/jrheum.080828","article-title":"Prednisone, lupus activity, and permanent organ damage","volume":"36","author":"Thamer","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib90","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2665-9913(19)30105-5","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study","volume":"2","author":"Apostolopoulos","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/annrheumdis-2011-200106","article-title":"A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus","volume":"71","author":"Rygg","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib92","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0961203309106917","article-title":"The Ped-APS registry: the antiphospholipid syndrome in childhood","volume":"18","author":"Av\u010din","year":"2009","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib93","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1136\/ard-2022-223328_bib94","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.autrev.2020.102693","article-title":"Childhood-Onset systemic lupus erythematosus-related antiphospholipid syndrome: a multicenter study with 1519 patients","volume":"19","author":"Islab\u00e3o","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2022-223328_bib95","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3899\/jrheum.151129","article-title":"Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: a prospective single-center study","volume":"43","author":"Joo","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib96","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ph14030273","article-title":"Evaluation of hydroxychloroquine blood concentrations and effects in childhood-onset systemic lupus erythematosus","volume":"14","author":"Zahr","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1136\/ard-2022-223328_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/09612033211062515","article-title":"Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis","volume":"31","author":"Andrade Balbi","year":"2022","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib98","first-page":"107","article-title":"[Application and safety of hydroxychloroquine in chronic disease among children]","volume":"59","author":"Sun","year":"2021","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1136\/ard-2022-223328_bib99","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy \u2014 implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: new mechanisms for old drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1136\/ard-2022-223328_bib101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2021.09.006","article-title":"Cardiovascular health in pediatric rheumatologic diseases","volume":"48","author":"Ardalan","year":"2022","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1136\/ard-2022-223328_bib102","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-223328_bib103","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.106.179568","volume":"114","author":"Kavey","year":"2006","journal-title":"Circulation"},{"key":"10.1136\/ard-2022-223328_bib104","doi-asserted-by":"crossref","first-page":"e000494","DOI":"10.1136\/lupus-2021-000494","article-title":"Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial","volume":"8","author":"Randell","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1136\/ard-2022-223328_bib105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12969-021-00624-z","article-title":"Utility of telemedicine in pediatric rheumatology during the COVID-19 pandemic","volume":"19","author":"Perdue","year":"2021","journal-title":"Pediatric Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3899\/jrheum.180139","article-title":"Grappa 2017 project report","volume":"94","author":"Callis Duffin","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib107","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00467-017-3767-4","article-title":"Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis","volume":"33","author":"Hogan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1136\/ard-2022-223328_bib109","first-page":"45","article-title":"Anti CD20 (rituximab) therapy in refractory pediatric rheumatic diseases","volume":"41","author":"Reis","year":"2016","journal-title":"Acta Reumatol Port"},{"key":"10.1136\/ard-2022-223328_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0961203314547793","article-title":"The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE","volume":"24","author":"Watson","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib111","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3899\/jrheum.140863","article-title":"Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases","volume":"42","author":"Tambralli","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib112","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/0961203315578764","article-title":"Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus","volume":"24","author":"Olfat","year":"2015","journal-title":"Lupus"},{"key":"10.1136\/ard-2022-223328_bib113","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British Society for rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223328_bib114","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223328_bib115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acr.21558","article-title":"Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus","volume":"64","author":"Mina","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard-2022-223328_bib116","doi-asserted-by":"crossref","first-page":"9-11","DOI":"10.1002\/art.41461","article-title":"Treat-to-Target from the patient perspective is Bowling for a perfect strike","volume":"73","author":"Schoemaker","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223328_bib117","doi-asserted-by":"crossref","first-page":"879208","DOI":"10.3389\/fped.2022.879208","article-title":"Health disparities in outcomes of pediatric systemic lupus erythematosus","volume":"10","author":"Vara","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1136\/ard-2022-223328_bib118","author":"Evidence. OCfE-bMLo"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724083912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2022-223328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:35:43Z","timestamp":1739504143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724083912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0003496724083912"],"URL":"https:\/\/doi.org\/10.1136\/ard-2022-223328","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2022-223328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}